Annual Short Term Debt
$2.43 B
-$122.27 M-4.80%
31 March 2024
Summary:
Takeda Pharmaceutical Company Limited annual short term debt is currently $2.43 billion, with the most recent change of -$122.27 million (-4.80%) on 31 March 2024. During the last 3 years, it has risen by +$2.23 billion (+1108.28%). TAK annual short term debt is now -72.69% below its all-time high of $8.88 billion, reached on 31 March 2019.TAK Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$4.37 B
+$1.64 B+60.29%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited quarterly short term debt is currently $4.37 billion, with the most recent change of +$1.64 billion (+60.29%) on 01 September 2024. Over the past year, it has increased by +$2.53 billion (+137.53%). TAK quarterly short term debt is now -50.81% below its all-time high of $8.88 billion, reached on 31 March 2019.TAK Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.8% | +137.5% |
| 3 y3 years | +1108.3% | +127.7% |
| 5 y5 years | -72.7% | +175.3% |
TAK Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.8% | +1108.3% | at high | +309.1% |
| 5 y | 5 years | -72.7% | +1108.3% | -22.2% | +2076.1% |
| alltime | all time | -72.7% | >+9999.0% | -50.8% | >+9999.0% |
Takeda Pharmaceutical Company Limited Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.37 B(+60.3%) |
| June 2024 | - | $2.73 B(+12.4%) |
| Mar 2024 | $2.43 B(-4.8%) | $2.43 B(-7.6%) |
| Dec 2023 | - | $2.63 B(+42.7%) |
| Sept 2023 | - | $1.84 B(-36.1%) |
| June 2023 | - | $2.88 B(+13.0%) |
| Mar 2023 | $2.55 B(+52.5%) | $2.55 B(-10.2%) |
| Dec 2022 | - | $2.84 B(-27.9%) |
| Sept 2022 | - | $3.93 B(+90.6%) |
| June 2022 | - | $2.06 B(+23.5%) |
| Mar 2022 | $1.67 B(+732.3%) | $1.67 B(+56.4%) |
| Dec 2021 | - | $1.07 B(-44.3%) |
| Sept 2021 | - | $1.92 B(+774.3%) |
| June 2021 | - | $219.56 M(+9.3%) |
| Mar 2021 | $200.82 M(-96.3%) | $200.82 M(-92.7%) |
| Dec 2020 | - | $2.76 B(+5.4%) |
| Sept 2020 | - | $2.62 B(-51.5%) |
| June 2020 | - | $5.40 B(-0.6%) |
| Mar 2020 | $5.43 B(-38.9%) | $5.43 B(-3.3%) |
| Dec 2019 | - | $5.62 B(+253.8%) |
| Sept 2019 | - | $1.59 B(-67.1%) |
| June 2019 | - | $4.83 B(-45.7%) |
| Mar 2019 | $8.88 B(>+9900.0%) | $8.88 B(+711.9%) |
| Dec 2018 | - | $1.09 B(+2.9%) |
| Sept 2018 | - | $1.06 B(+9819.4%) |
| June 2018 | - | $10.72 M(+6229.3%) |
| Mar 2018 | $169.40 K(-100.0%) | $169.40 K(-100.0%) |
| Dec 2017 | - | $1.24 B(-0.2%) |
| Sept 2017 | - | $1.24 B(-31.5%) |
| June 2017 | - | $1.82 B(-62.7%) |
| Mar 2017 | $4.87 B(+139.8%) | $4.87 B(+140.4%) |
| Dec 2016 | - | $2.03 B(-2.9%) |
| Sept 2016 | - | $2.09 B(+0.1%) |
| June 2016 | - | $2.09 B(+2.7%) |
| Mar 2016 | $2.03 B | $2.03 B(+144.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | - | $829.98 M(-0.5%) |
| Sept 2015 | - | $833.96 M(+2.4%) |
| June 2015 | - | $814.79 M(-2.2%) |
| Mar 2015 | $832.81 M(-44.8%) | $832.81 M(-45.3%) |
| Dec 2014 | - | $1.52 B(+0.7%) |
| Sept 2014 | - | $1.51 B(-0.0%) |
| June 2014 | - | $1.51 B(+0.1%) |
| Mar 2014 | $1.51 B(+7210.6%) | $1.51 B(>+9900.0%) |
| Dec 2013 | - | $13.55 M(-0.5%) |
| Sept 2013 | - | $13.61 M(-12.1%) |
| June 2013 | - | $15.48 M(-25.0%) |
| Mar 2013 | $20.66 M(-99.3%) | $20.66 M(+6.3%) |
| Dec 2012 | - | $19.43 M(-0.1%) |
| Sept 2012 | - | $19.46 M(-99.4%) |
| June 2012 | - | $3.04 B(+3.7%) |
| Mar 2012 | $2.93 B(+5811.4%) | $2.93 B(-57.9%) |
| Dec 2011 | - | $6.97 B(-6.4%) |
| Sept 2011 | - | $7.44 B(>+9900.0%) |
| June 2011 | - | $15.74 M(-68.3%) |
| Mar 2011 | $49.62 M(+41.3%) | $49.62 M(+26.3%) |
| Dec 2010 | - | $39.28 M(+10.0%) |
| Sept 2010 | - | $35.69 M(+3.3%) |
| June 2010 | - | $34.56 M(-1.6%) |
| Mar 2010 | $35.12 M(+8.2%) | $35.12 M(+0.1%) |
| Dec 2009 | - | $35.10 M(+1.8%) |
| Sept 2009 | - | $34.48 M(+6.2%) |
| Mar 2009 | $32.46 M(-3.5%) | $32.46 M(-20.4%) |
| Dec 2008 | - | $40.76 M |
| Mar 2008 | $33.64 M(-58.5%) | - |
| Mar 2007 | $81.13 M(+4.9%) | - |
| Mar 2006 | $77.36 M(-35.9%) | - |
| Mar 2005 | $120.74 M(+26.1%) | - |
| Mar 2004 | $95.74 M(+46.9%) | - |
| Mar 2003 | $65.16 M(-14.6%) | - |
| Mar 2002 | $76.30 M(+1.9%) | - |
| Mar 2001 | $74.91 M | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual short term debt?
- What is the all time high annual short term debt for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual short term debt year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly short term debt?
- What is the all time high quarterly short term debt for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly short term debt year-on-year change?
What is Takeda Pharmaceutical Company Limited annual short term debt?
The current annual short term debt of TAK is $2.43 B
What is the all time high annual short term debt for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual short term debt is $8.88 B
What is Takeda Pharmaceutical Company Limited annual short term debt year-on-year change?
Over the past year, TAK annual short term debt has changed by -$122.27 M (-4.80%)
What is Takeda Pharmaceutical Company Limited quarterly short term debt?
The current quarterly short term debt of TAK is $4.37 B
What is the all time high quarterly short term debt for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly short term debt is $8.88 B
What is Takeda Pharmaceutical Company Limited quarterly short term debt year-on-year change?
Over the past year, TAK quarterly short term debt has changed by +$2.53 B (+137.53%)